4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001615774-17-000876
10% owner sold 425,000 shares at an average $30.82 ($13,098,000)
From the SEC's structured data for this filing
Trades in this filing
VIVO VENTURES VII, LLC · 10% owner
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-02-28 | Sale : show line 1 in the form | −195,734 | $30.50 | $5,969,887 | 3,017,798 | I |
| 2017-02-28 | Sale : show line 2 in the form | −4,266 | $30.50 | $130,113 | 65,771 | I |
| 2017-03-01 | Sale : show line 3 in the form | −97,867 | $30.98 | $3,031,920 | 2,919,931 | I |
| 2017-03-01 | Sale : show line 4 in the form | −2,133 | $30.98 | $66,080 | 63,638 | I |
| 2017-03-02 | Sale : show line 5 in the form | −122,334 | $31.20 | $3,816,821 | 2,797,597 | I |
| 2017-03-02 | Sale : show line 6 in the form | −2,666 | $31.20 | $83,179 | 60,972 | I |
| Open-market sales · 425,000 sh · avg $30.82 · $13,098,000 | ||||||
Loading xslF345X03/s105466_form4.xml…